Business
Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor
Recruitment of Chief Financial Officer, Chief Legal Officer, and Chief People Officer reflects Inventiva’s organizational build-out as it advances toward potential commercialization.Axel-Sven Malkomes joins as Chief Financial Officer, bringing more than 30 years of investment banking and corporate leadership experience, including recently playing an instrumental role in CureVac’s acquisition by BioNTech.Susan Coles joins as Chief Legal Officer, bringing more than 25 years of experience guiding l
About this update from Inventiva Sa
[{"type":"image","alt":"INVENTIVA","displaySize":"","headline":null,"caption":"INVENTIVA","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":142,"url":"https://media.zenfs.com/en/globenewswire.com/fef5472de2e52c88120abbdb39dcd123"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TGC453pbWugzpJxljVU3dA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5OQ--/https://media.zenfs.com/en/globenewswire.com/fef5472de2e52c88120abbdb39dcd123","width":300,"height":142},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/TGC453pbWugzpJxljVU3dA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE5OQ--/https://media.zenfs.com/en/globenewswire.com/fef5472de2e52c88120abbdb39dcd123","width":300,"height":142}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Recruitment of Chief Financial Officer, Chief Legal Officer, and Chief People Officer reflects Inventiva’s organizational build-out as it advances toward potential commercialization.","length":182,"tagName":"p"}]},{"val":[{"type":"text","content":"Axel-Sven Malkomes joins as Chief Financial Officer, bringing more than 30 years of investment banking and corporate leadership experience, including recently playing an instrumental role in CureVac’s acquisition by BioNTech.","length":225,"tagName":"p"}]},{"val":[{"type":"text","content":"Susan Coles joins as Chief Legal Officer, bringing more than 25 years of experience guiding life science companies through growth and transformation.","length":149,"tagName":"p"}]},{"val":[{"type":"text","content":"Pamela Herbster joins as Chief People Officer, bringing over 25 years of biopharmaceutical experience in developing human resource strategies and programs that elevate organizational performance and cultivate high-performing, people-centric cultures.","length":250,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":806,"olType":false},{"type":"text","content":" ","length":12,"tagName":"p"},{"type":"text","content":"Daix (France), New York (United States), April 22, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced three new members of its leadership team: Axel-Sven Malkomes as Chief Financial Officer, Susan Coles...